These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24713)

  • 1. Fate of [14C]warfarin in guinea-pigs: effect of a concomitant single dose of salicylate.
    Wong LT; Solomonraj G; Thomas BH
    J Pharm Pharmacol; 1978 Apr; 30(4):240-3. PubMed ID: 24713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of salicylate on the fate of [14C]sulfinpyrazone in the rat.
    Wong LT; Buttar HS; Solomonraj G; Thomas BH
    Can J Physiol Pharmacol; 1982 Jun; 60(6):763-8. PubMed ID: 7116223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sodium salicylate on the fate of warfarin in the rat.
    Coldwell BB; Buttar HS; Paul CJ; Thomas BH
    Toxicol Appl Pharmacol; 1974 Jun; 28(3):374-84. PubMed ID: 4851695
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of salicylate on the biliary excretion of 14C-bishydroxycoumarin in rat.
    Buttar HS; Coldwell BB; Thomas BH
    Br J Pharmacol; 1973 Jun; 48(2):278-87. PubMed ID: 4126254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.
    Kurebayashi H; Betsui H; Ohno Y
    Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sodium salicylate on elimination kinetics of indomethacin and bile production in dogs.
    Beck WS; Dietzel K; Geisslinger G; Engler H; Vergin H; Brune K
    Drug Metab Dispos; 1990; 18(6):962-7. PubMed ID: 1981545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological clearance of TEGDMA in guinea pigs.
    Reichl FX; Durner J; Kunzelmann KH; Hickel R; Spahl W; Hume WR; Moes GW; Kehe K; Walther U; Forth W
    Arch Toxicol; 2001 Mar; 75(1):22-7. PubMed ID: 11357517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of the new antirheumatic agent ethyl 4-(3,4-dimethoxyphenyl)- 6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (TAK-603) in rats and dogs.
    Tagawa Y; Kiyota Y; Yoshimura Y; Motohashi M; Tanayama S
    Arzneimittelforschung; 1998 Jul; 48(7):750-7. PubMed ID: 9706376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug interaction. Effects of salicylate on pharmacokinetics of valproic acid in rats.
    Yu HY; Shen YZ; Sugiyama Y; Hanano M
    Drug Metab Dispos; 1990; 18(1):121-6. PubMed ID: 1970771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between diflunisal and warfarin.
    Serlin MJ; Mossman S; Sibeon RG; Tempero KF; Breckenridge AM
    Clin Pharmacol Ther; 1980 Oct; 28(4):493-8. PubMed ID: 7408409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aspirin on 14C-pirprofen disposition in rats.
    Thompson TA; Borman CH; Goodblatt RS; Roth WJ
    J Pharm Sci; 1979 Aug; 68(8):996-8. PubMed ID: 480180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of the new pyrimidine derivative NS-7, a novel Na+/Ca2+ channel blocker. 1st communication: plasma concentrations and excretions after a single intravenous 14C-NS-7 injection to rats, dogs and monkeys.
    Nonaka K; Tsujioka T; Tougou K; Mukai H
    Arzneimittelforschung; 2003; 53(9):612-20. PubMed ID: 14558434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic disposition of 6-ethyl-3-(1H-tetrazol-5-yl)-chromone, a new antiallergic agent, in the rat, guinea-pig, rabbit, dog and monkey.
    Kanai Y; Nakai Y; Nakajima N; Tanayama S
    Xenobiotica; 1979 Jan; 9(1):33-50. PubMed ID: 104449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of quinidine on digoxin distribution and elimination in guinea pigs.
    Sato J; Sawada Y; Iga T; Hanano M
    J Pharm Sci; 1983 Oct; 72(10):1137-41. PubMed ID: 6644558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition in rats and dogs of ciglitazone, a new antidiabetic agent.
    Torii H; Yoshida K; Tsukamoto T; Tanayama S
    Xenobiotica; 1984 Mar; 14(3):259-68. PubMed ID: 6711015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of tenidap sodium on the pharmacodynamics and plasma protein binding of warfarin in healthy volunteers.
    Apseloff G; Wilner KD; Gerber N
    Br J Clin Pharmacol; 1995; 39 Suppl 1(Suppl 1):29S-33S. PubMed ID: 7547090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
    Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF
    Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of salicylate on the fate of bishydroxycoumarin in the rat.
    Thomas BH; Coldwell BB; Buttar HS; Zeitz W
    Can J Physiol Pharmacol; 1973 Mar; 51(3):205-12. PubMed ID: 4122297
    [No Abstract]   [Full Text] [Related]  

  • 19. [Absorption, distribution, metabolism and excretion of netilmicin in rats (III). Metabolic fate of 14C-netilmicin after intramuscular administration (author's transl)].
    Uda F; Fujino A; Tokiwa T
    Jpn J Antibiot; 1982 Apr; 35(4):967-78. PubMed ID: 7097991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatic amino acid metabolites as potential protein binding inhibitors in human uremic plasma.
    Tavares-Almeida I; Gulyassy PF; Depner TA; Jarrard EA
    Biochem Pharmacol; 1985 Jul; 34(14):2431-8. PubMed ID: 4015686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.